Literature DB >> 29221345

A rare mixed breast cancer of intraductal and solid papillary with tubular carcinoma histotypes in a young woman.

Xiaohui Zhang1, Jie Shi2, Yidong Zhou1, Feng Mao1, Yan Lin1, Jinghong Guan1, Zhiyong Liang2, Qiang Sun1.   

Abstract

Mixed breast cancer, especially of uncommon breast cancer histotypes, is rare, limiting our understanding of the disease and influencing diagnostic and management outcomes. We report a case of mixed breast cancer, with features of intraductal and solid papillary and tubular carcinomas, which appeared in a young patient. Physical examination, ultrasonography, molybdenum target mammography, and histopathology were performed for a definitive diagnosis. Tumor resection followed by radiotherapy and adjuvant chemotherapy was selected as the therapeutic strategy, and the patient was followed up thrice post treatment. We discuss the detailed diagnosis, treatment, and follow-up, together with a literature review of mixed breast cancer, to help optimize clinical management of mixed breast cancer.

Entities:  

Keywords:  Breast cancer; mixed histology; papillary carcinoma; tubular carcinoma

Year:  2017        PMID: 29221345      PMCID: PMC5708519          DOI: 10.21037/jtd.2017.07.105

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  13 in total

Review 1.  Solid papillary carcinoma of the breast: a pathologically and clinically distinct breast tumor.

Authors:  Jinous Saremian; Marilin Rosa
Journal:  Arch Pathol Lab Med       Date:  2012-10       Impact factor: 5.534

2.  Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.

Authors:  Suzuko Moritani; Shu Ichihara; Ryoji Kushima; Hidetoshi Okabe; Masamichi Bamba; Tadao K Kobayashi; Takanori Hattori
Journal:  Virchows Arch       Date:  2007-03-22       Impact factor: 4.064

Review 3.  Tubular carcinoma of the breast: a retrospective analysis and review of the literature.

Authors:  Timothy Sullivan; Rita Abi Raad; Saveli Goldberg; Sherif I Assaad; Michele Gadd; Barbara L Smith; Simon N Powell; Alphonse G Taghian
Journal:  Breast Cancer Res Treat       Date:  2005-10       Impact factor: 4.872

4.  Fibro-adenoma of the breast.

Authors:  S Wilkinson; A P Forrest
Journal:  Br J Surg       Date:  1985-10       Impact factor: 6.939

Review 5.  Breast carcinoma arising in microglandular adenosis: a review of the literature.

Authors:  Afshin Salarieh; Nour Sneige
Journal:  Arch Pathol Lab Med       Date:  2007-09       Impact factor: 5.534

Review 6.  Unusual malignant tumors of the breast: MRI features and pathologic correlation.

Authors:  Anna Linda; Chiara Zuiani; Rossano Girometti; Viviana Londero; Piernicola Machin; Giovanni Brondani; Massimo Bazzocchi
Journal:  Eur J Radiol       Date:  2009-05-14       Impact factor: 3.528

7.  Rare breast cancer subtypes: histological, molecular, and clinical peculiarities.

Authors:  Maria Vittoria Dieci; Enrico Orvieto; Massimo Dominici; PierFranco Conte; Valentina Guarneri
Journal:  Oncologist       Date:  2014-06-26

8.  Trends in incidence rates of invasive lobular and ductal breast carcinoma.

Authors:  Christopher I Li; Benjamin O Anderson; Janet R Daling; Roger E Moe
Journal:  JAMA       Date:  2003-03-19       Impact factor: 56.272

9.  Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.

Authors:  Ankit Bharat; Feng Gao; Julie A Margenthaler
Journal:  Am J Surg       Date:  2009-10       Impact factor: 2.565

10.  Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.

Authors:  A Goldhirsch; E P Winer; A S Coates; R D Gelber; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2013-08-04       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.